Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 September 2021 | Story Lacea Loader

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State (UFS), will answer questions about the COVID-19 vaccine and its affects.  

The webinar will address questions such as the following:

• what vaccination is and how it works
• how vaccines are developed and how we know they are safe and effective
• how the COVID-19 vaccine works and how it can protect you
• the side effects of the vaccine
• the risks vs benefits of the vaccine.

You can also forward questions prior to the webinar to grimbeekl@ufs.ac.za

Date: Friday 10 September 2021
Time: 11:00-12:00
Register for the webinar


News Archive

Office of Technology Transfer receives multimillion rand grant
2016-01-15


The university’s Office of Technology Transfer (OTT) received multimillion rand funding for the office to provide much needed support for academia to have their ideas and research effectively turned into business ventures.

This grant of over R4 million by the National Intellectual Property Management Office (NIPMO), under the auspices of the Department of Science and Technology, will help the OTT to provide an enabling environment for cooperation between academia and industry to transform innovation emanating from research and development at the UFS into business ventures.

“Research and innovation plays a prominent role in the financial sustainability of an institution, in that it has the capacity to be the largest generator of third-steam income,” says Gerhard Verhoef, Director: Contracts and Innovation at the Directorate Research Development at the UFS.

“The OTT is a very new office and this grant, provided over three years, will help us fulfil our mandate.”

NIPMO aims to ensure that recipients of funding from a government funding agency assess, record and report on the benefit to society of IP emanating from publicly-financed research and development. Recipients must protect IP emanating from publicly-financed research and development from appropriation and ensure that it is available to the people of South Africa. A recipient must identify commercialisation opportunities for IP emanating from publicly-financed research and development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept